CZI Co-Founder and Co-CEO Priscilla Chan sat down with Shana Kelley, president of the Chan Zuckerberg Biohub Chicago, and Patricia Brennan, vice president of science technology and general manager for science at CZI, to discuss the exciting work that remains ahead and the progress that has been made in the past year in developing tools to better understand and measure disease.
The discussion focused on concrete efforts to speed up biomedical research and show advancements made toward CZI’s goal of curing, preventing, or managing all diseases by the end of the century, from the introduction of a platform that makes it simple for researchers and biologists to access cutting-edge AI-powered cell models to the first-of-its-kind sensor to track inflammation in real-time at the Chicago Biohub.
